Peter Blume-Jensen - President and CEO, Director at Acrivon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ACRV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Peter Blume-Jensen since 12/22/2023

Holdings reported by Peter Blume-Jensen for Acrivon Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.34M $15.1M $6.44 Nov 21, 2024 Direct
Common Stock 317K $2.04M $6.44 Nov 21, 2024 Indirect
Stock Option (Right to Buy) 225K Mar 1, 2024 Direct Common Stock
Stock Option (Right to Buy) 90.1K Mar 1, 2024 Indirect Common Stock

Transactions reported by Peter Blume-Jensen for Acrivon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.